Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Radiology|December 18, 2007
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CTGerwin P Schmidt, Andrea Baur-Melnyk, Alexander Haug, et al.
European Journal of Radiology|February 11, 2016
Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancerDietmar Tamandl, Julie Ta, Rainer Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2010
Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT studyMona Mustafa, Torsten Kuwert, Kathrin Weber, et al.
Annals of Nuclear Medicine|April 3, 2015
Role of (64)CuCl 2 PET/CT in staging of prostate cancerEnza Capasso, Silvia Durzu, Sara Piras, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 26, 2021
Arthroscopic lateral retinacular release improves patello-femoral and femoro-tibial kinematics in patients with isolated lateral retinacular tightnessFlorian Pohlig, Ulrich Lenze, Florian Walter Lenze, et al.
Clinical Nuclear Medicine|November 13, 2018
A Diagnostic Algorithm That Combines Quantitative 18F-FDG PET Parameters and Contrast-Enhanced CT Improves Posttherapeutic Locoregional Restaging and Prognostication of Survival in Patients With Esophageal CancerDietmar Tamandl, Barbara Fueger, Alexander Haug, et al.
Endocrine-Related Cancer|January 12, 2024
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasmsPhilipp Melhorn, Peter Mazal, Ladislaia Wolff, et al.
Biology|November 27, 2021
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of AgeRaffaella Calabretta, Philipp B Staber, Christoph Kornauth, et al.
Cancer Immunology Research|June 26, 2020
In Human Visualization of Ibrutinib-Induced CLL Compartment ShiftMarius E Mayerhoefer, Alexander Haug, Ulrich Jäger, et al.
Cancers|December 22, 2019
RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 PatientsDominik Berzaczy, Alexander Haug, Philipp B Staber, et al.
Pageof 8